News Breaks |
|
|
| January 29, 2013 |
| 07:04 EDT |  | WCRX | Warner Chilcott recent weakness a buying opportunity, says UBS UBS said Warner Chilcott shares were weak following misinterpreted comments by Actavis management regarding the potential for generic mesalamine. The analyst does not see any new threats and would be buyers of Warner Chilcott and said shares reflect a worst case scenario. Shares are Buy rated with a $24 price target. |
|
|
News For WCRX From The Last 14 Days Check below for free stories on WCRX the last two weeks. |
|
|
| May 21, 2013 |
| 10:00 EDT |  | WCRX | On The Fly: Analyst Downgrade Summary Today's noteworthy downgrades include: Acquity Group (AQ) downgraded to Neutral from Buy at Roth Capital... Beazer Homes (BZH) downgraded to Neutral from Buy at Sterne Agee... CME Group (CME) downgraded to Neutral from Outperform at Macquarie... Carnival (CCL) downgraded to Neutral from Buy at UBS... Coach (COH) downgraded to Equal Weight from Overweight at Morgan Stanley... Deutsche Bank (DB) downgraded to Neutral from Overweight at JPMorgan... First Republic Bank (FRC) downgraded to Hold from Buy at Jefferies... Franklin Resources (BEN) downgraded to Neutral from Outperform at Macquarie... Life Technologies (LIFE) downgraded to Underperform from Outperform at CLSA... Oil States (OIS) downgraded to Neutral from Buy at Sterne Agee... Raymond James (RJF) downgraded to Market Perform from Outperform at Wells Fargo... VF Corp. (VFC) downgraded to Market Perform from Outperform at Wells Fargo... WellCare (WCG) downgraded to Neutral from Buy at Goldman... Huaneng Power (HNP) downgraded to Neutral from Buy at Citigroup... Comerica (CMA) downgraded to Neutral from Buy at DA Davidson... Beazer Homes (BZH) downgraded at Sterne Agee... Oil States (OIS) downgraded at Sterne Agee... eHealth (EHTH) downgraded to Neutral from Buy at Lazard Capital... Carnival (CCL) downgraded to Market Perform from Outperform at Wells Fargo... Warner Chilcott (WCRX) downgraded to Neutral from Positive at Susquehanna. |
|
| 07:18 EDT |  | WCRX | Warner Chilcott downgraded to Neutral from Positive at Susquehanna
Subscribe for More Information |
|
| May 20, 2013 |
| 16:51 EDT |  | WCRX | Actavis, Warner Chilcott deal includes $160M termination fee
Subscribe for More Information |
|
| 16:22 EDT |  | WCRX | On The Fly: Closing Wrap
Subscribe for More Information |
|
| 14:27 EDT |  | WCRX | Actavis price target raised to $140 from $101 at Morgan Stanley Morgan Stanley raised Actavis's price target to $140 due to Warner Chilcott (WCRX) deal accretion. Shares are Overweight rated. |
|
| 14:05 EDT |  | WCRX | Warner Chilcott downgraded to Hold from Buy at Needham
Subscribe for More Information |
|
| 13:06 EDT |  | WCRX | On The Fly: Midday Wrap Stocks on Wall Street were modestly higher at midday as the Dow and S&P seek to continue their march higher after closing last week at record levels. ECONOMIC EVENTS: In the U.S., the light domestic economic calendar included the Chicago Fed National Activity index, which slipped to -0.53 for April from its prior reading of -0.23. In Asia, the Hang Seng and Shanghai Composite both climbed after Chinese home prices were reported to have risen in April. COMPANY NEWS: Yahoo (YHOO) confirmed it is buying social media platform Tumblr for $1.1B, as widely reported over the weekend, and promised "not to screw it up" in its press release to announce the deal... Actavis (ACT) agreed to acquire Warner Chilcott (WCRX) in a stock-for-stock transaction valued at approximately $8.5B. The deal, which was approved by the boards of both companies, equates to a value of $20.08 per Warner Chilcott share based on Actavis' closing share price on Friday, the companies said. MAJOR MOVERS: Among the notable gainers were some other companies with M&A news: Acquity Group (AQ) shares more than doubled after Accenture (ACN) agreed to buy the company for $13.00 per American Depositary Share, and Pactera Technology (PACT) gained 31% after receiving a non-binding proposal from a Blackstone (BX) affiliate to be taken private for $7.50 per ADS. Among the noteworthy losers was XenoPort (XNPT), which fell 11% after one of its drugs failed in a Phase III trial for multiple sclerosis spasticity. Also lower were shares of Red Hat (RHT), which slid 4% following a downgrade to Market Perform at BMO Capital. INDICES: Near 1 pm ET, the Dow was up 13.67, or 0.09%, to 15,368.07; the Nasdaq was up 1.13, or 0.03%, to 3,500.10; and the S&P 500 was up 2.18, or 0.13%, to 1,669.65. |
|
| 11:56 EDT |  | WCRX | Options with decreasing implied volatility: SGMO WCRX TSLA CSC SUPN
|
|
| 11:16 EDT |  | WCRX | Actavis, Warner Chilcott company worth $128 per share, says Leerink Leerink estimates the value of the combined Actavis (ACT) and Warner Chilcott (WCRX) company at $128 per share. The firm sees some upside for shareholders of the new company should Warner Chilcott's brands prove durable in 2014. Leerink has a Market Perform on shares of Actavis. |
|
| 10:43 EDT |  | WCRX | Actavis price target rasied to $145 from $124 at BMO Capital
Subscribe for More Information |
| |
| 09:57 EDT |  | WCRX | Actavis hosted a conference call
Subscribe for More Information |
|
| 09:26 EDT |  | WCRX | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 09:07 EDT |  | WCRX | Warner Chilcott announces Irish takeover rules revision
Subscribe for More Information |
|
| 07:21 EDT |  | WCRX | Warner Chilcott volatility elevated into Actavis acquiring for $8.5B
Subscribe for More Information |
|
| 07:11 EDT |  | WCRX | Actavis to acquire Warner Chilcott for $8.5B in stock
Subscribe for More Information |
|
| 07:08 EDT |  | WCRX | Actavis to acquire Warner Chilcott in $8.5B stock-for-stock transaction
Subscribe for More Information |
|
| May 17, 2013 |
| 14:48 EDT |  | WCRX | Actavis may bid for Warner Chilcott to ward off takeover, Reuters says
Subscribe for More Information |
|
| 13:56 EDT |  | WCRX | Actavis may purchase Warner Chilcott as takeover defense, Reuters reports Over past few weeks, Actavis (ACT) has "spurned approaches" from Valeant (VRX) and Mylan (MYL), and has instead pursued a bid for Warner Chilcott (WCRX), according to Reuters, citing people familiar with the situation. |
|
| 13:19 EDT |  | WCRX | Rumor: Warner Chilcott goes positive following chatter it canceled a conference Shares of Warner Chilcot (WCRX) have turned positive following conjecture it canceled out of a sell-side conference. Note that Warner Chilcott is engaged in preliminary discussions with Actavis (ACT) regarding a potential business combination transaction. |
|
| 10:36 EDT |  | WCRX | Leerink's major/specialty pharma analyst holds analyst/Industry conference call
Subscribe for More Information |
| |
|
|
|
|